Literature DB >> 10026344

Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease.

J Danesh1, Y Wong, M Ward, J Muir.   

Abstract

OBJECTIVE: To study possible associations between coronary heart disease and serological evidence of persistent infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus.
DESIGN: Population based, case-control study, nested within a randomised trial.
SETTING: Five general practices in Bedfordshire, UK. INDIVIDUALS: 288 patients with incident or prevalent coronary heart disease and 704 age and sex matched controls.
RESULTS: High concentrations of serum IgG antibodies to H pylori were present in 54% of cases v 46% of controls, with corresponding results for C pneumoniae seropositivity (33% v 33%), and cytomegalovirus seropositivity (40% v 31%). After adjustments for age, sex, smoking, indicators of socioeconomic status, and standard risk factors, the odds ratios (95% confidence intervals) for coronary heart disease of seropositivity to these agents were: 1.28 (0.93 to 1.75) for H pylori, 0.95 (0.66 to 1.36) for C pneumoniae, and 1.40 (0.96 to 2. 05) for cytomegalovirus.
CONCLUSIONS: There is no good evidence of strong associations between coronary heart disease and serological markers of persistent infection with H pylori, C pneumoniae, or cytomegalovirus. To determine the existence of moderate associations between these agents and disease, however, larger scale studies will be needed that can keep residual confounders to a minimum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026344      PMCID: PMC1728960          DOI: 10.1136/hrt.81.3.245

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

1.  Chlamydia pneumoniae and acute myocardial infarction in Jerusalem.

Authors:  J D Kark; M Leinonen; O Paltiel; P Saikku
Journal:  Int J Epidemiol       Date:  1997-08       Impact factor: 7.196

2.  Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men.

Authors:  P H Whincup; M A Mendall; I J Perry; D P Strachan; M Walker
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 3.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

Review 4.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

Authors:  P Libby; D Egan; S Skarlatos
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

5.  Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.

Authors:  J Danesh; R Peto
Journal:  BMJ       Date:  1998-04-11

6.  Persistent infection and vascular disease: a systematic review.

Authors:  J Danesh; P Appleby
Journal:  Expert Opin Investig Drugs       Date:  1998-05       Impact factor: 6.206

7.  Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Authors:  S Gupta; E W Leatham; D Carrington; M A Mendall; J C Kaski; A J Camm
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

8.  Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study.

Authors:  N J Wald; M R Law; J K Morris; A M Bagnall
Journal:  BMJ       Date:  1997-11-08

9.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

10.  Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.

Authors:  H Miettinen; S Lehto; P Saikku; S M Haffner; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Eur Heart J       Date:  1996-05       Impact factor: 29.983

View more
  17 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.

Authors:  Ya-Nan Ji; Li An; Ping Zhan; Xiao-Hu Chen
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

3.  Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study.

Authors:  Michiel B Haeseker; Evelien Pijpers; Nicole Htm Dukers-Muijrers; Patty Nelemans; Christian Jpa Hoebe; Cathrien A Bruggeman; Annelies Verbon; Valère J Goossens
Journal:  Immun Ageing       Date:  2013-07-23       Impact factor: 6.400

Review 4.  Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?

Authors:  J L Mehta; F Romeo
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.

Authors:  N J Wald; M R Law; J K Morris; X Zhou; Y Wong; M E Ward
Journal:  BMJ       Date:  2000-07-22

6.  Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling.

Authors:  Irina N Baranova; Roger Kurlander; Alexander V Bocharov; Tatyana G Vishnyakova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Authors:  Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L Telford; Cosima T Baldari; Sergio Romagnani; Antonio Cassone; Mario M D'Elios; Gianfranco Del Prete
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

Review 8.  Helicobacter pylori in intensive care: why we should be interested.

Authors:  Megan S Robertson; Robert L Clancy; John F Cade
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

9.  Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae.

Authors:  S Padmavati; U Gupta; H K Agarwal
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

10.  Evaluating clinical periodontal measures as surrogates for bacterial exposure: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Ryan T Demmer; Panos N Papapanou; David R Jacobs; Moïse Desvarieux
Journal:  BMC Med Res Methodol       Date:  2010-01-07       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.